Results

eNauka >  Results >  565Tip A phase I/II dose-escalation and expansion study of ZN-c5, an oral selective estrogen receptor degrader (SERD), as monotherapy and in combination with palbociclib in patients with advanced estrogen receptor (ER)+/HER2-breast cancer
Title: 565Tip A phase I/II dose-escalation and expansion study of ZN-c5, an oral selective estrogen receptor degrader (SERD), as monotherapy and in combination with palbociclib in patients with advanced estrogen receptor (ER)+/HER2-breast cancer
Authors Abramson, V; ...; Andric, Zoran G  ; Milovic-Kovacevic, Marijana M  ; Trifunovic, Jasna D; ...; (broj, koautora 16)
Issue Date: 2021
Publication: ANNALS OF ONCOLOGY
ISSN: 0923-7534 Annals of Oncology Search Idenfier
Publisher: ESMO
Type: Conference Paper
Collation: vol. 32 br. Suppl 5 str. S619-S619
DOI: 10.1016/j.annonc.2021.08.1087
WoS-ID: 000700527701031
URI: https://enauka.gov.rs/handle/123456789/810763
URL: https://www.annalsofoncology.org/article/S0923-7534(21)03316-0/fulltext
Project: Zentalis Pharmaceuticals
Metadata source: (Preuzeto iz Nasi u WoS)
M-category: 
Mp. category will be shown later

5
WEB OF SCIENCETM
Altmetric
Dimensions
Unpaywall

Google ScholarTM

Items in eNauka are protected by copyright, with all rights reserved, unless otherwise indicated.